Hermetica Superfood Encyclopedia
The Short Answer
Phymatosorus scolopendria contains phenolic acids (notably p-coumaroyl tartaric acid at ~28% of hexane leaf extract), flavonoids including cirsimaritin and isoxanthohumol, and stilbenes such as resveratrol, which collectively inhibit COX-2, bacterial biofilm formation, and free-radical activity. In vitro assays demonstrate anti-biofilm activity against Staphylococcus epidermidis at 128 µg/mL and selective COX-2 inhibition attributable to kaempferol and cirsimaritin, though no human clinical trials have been conducted to confirm these effects.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordTaulalo Phymatosorus scolopendria benefits
Taulalo — botanical close-up
Health Benefits
**Wound and Sore Healing**
Samoan traditional use for topical sores is supported by in vitro antimicrobial and anti-biofilm data; isoxanthohumol and resveratrol in rhizome extracts disrupt S. epidermidis biofilm at 128 µg/mL, potentially limiting wound infection progression.
**Anti-inflammatory Activity**
Flavonoids cirsimaritin and kaempferide selectively inhibit COX-2 over COX-1 in vitro, reducing prostaglandin synthesis relevant to inflammatory sore and skin conditions documented in Pacific ethnomedicine.
**Antioxidant Protection**
Methanolic and hexane extracts demonstrate DPPH free-radical scavenging activity, attributable to polyphenols including protocatechuic acid 4-O-glucoside and pyrogallol, though potency is lower than reference standards gallic acid and vitamin C.
**Antimicrobial and Antibiofilm Effects**
Polyphenols such as resveratrol and kaempferide downregulate bacterial adhesion and quorum-sensing genes (rsbU, spa), increase antibiotic susceptibility, and destabilize biofilm architecture in S. epidermidis cultures.
**Bronchodilator Support**
Ethnomedicinal use among tribal populations in Southeast Asia and the Pacific includes treatment of respiratory conditions; while the precise bronchodilator mechanism is uncharacterized, lipophilic compounds in hexane extracts may modulate smooth muscle tone.
**Insect Repellent Properties**
Traditional preparations of leaves are applied externally as insect repellents; fatty acid derivatives including dodecanoic acid 1,2,3-propanetriyl ester and hexadecanoic acid 4-nitrophenyl ester identified by GC-MS may contribute to this bioactivity.
**Antibacterial Synergy with Antibiotics**
In vitro evidence suggests phenolic compounds interfere with quorum sensing and α-toxin production, potentially enhancing conventional antibiotic efficacy against gram-positive organisms when used as adjunctive preparations.
Origin & History
Natural habitat
Phymatosorus scolopendria is a tropical fern native to the Pacific Islands, East Africa, and parts of Southeast Asia, growing epiphytically or terrestrially in humid, shaded forest environments. In Samoa and other Polynesian island groups, it thrives on rocky substrates and tree trunks in lowland and coastal forests. The plant has not been formally cultivated for commercial purposes and is harvested from wild populations by traditional healers.
“In Samoan traditional medicine, Taulalo is classified among plants used for treating skin sores and is considered functionally similar to awawa (Microsorum grossum), reflecting a broader Polynesian pattern of using fern fronds and rhizomes in wound-care preparations. Across the Pacific Islands and parts of East Africa and Southeast Asia, various Phymatosorus species have served as insect repellents, respiratory remedies, and topical anti-inflammatories within indigenous healing systems, typically prepared as poultices or decoctions without standardization. The plant's role in Samoan healing reflects a sophisticated empirical pharmacopoeia developed over centuries by communities with limited access to Western pharmaceutical resources. Historical documentation of its use is largely confined to ethnobotanical surveys rather than classical materia medica texts, and its therapeutic identity is closely tied to geographic and linguistic communities rather than global trade networks.”Traditional Medicine
Scientific Research
Available evidence for Phymatosorus scolopendria is restricted to in vitro phytochemical and bioassay studies; no clinical trials, animal pharmacokinetic studies, or randomized controlled trials in humans have been published as of the available literature. GC-MS profiling of methanolic leaf extracts and LC-MS analysis of hexane and aqueous rhizome/leaf fractions have characterized the major bioactive constituents, while DPPH radical scavenging assays and microdilution anti-biofilm assays (minimum inhibitory concentration of 128 µg/mL against S. epidermidis) represent the primary quantitative efficacy data. COX-2 inhibition has been assessed in enzymatic assays attributing activity to cirsimaritin and kaempferide, but IC50 values and selectivity ratios against human isoforms have not been systematically reported. The overall evidence base is preliminary and insufficient to establish efficacy, safety thresholds, or dosing in human populations.
Preparation & Dosage
Traditional preparation
**Traditional Topical Preparation**
Fresh or dried leaves are crushed or macerated in water and applied as a poultice directly to skin sores and wounds; no standardized preparation protocol has been documented.
**Methanolic Extract (Research Use)**
Laboratory studies use crude methanolic leaf extracts; in vitro effective concentrations begin at 128 µg/mL for anti-biofilm activity; no equivalent human dose has been established.
**Hexane Extract (Research Use)**
Hexane fractionation isolates lipophilic flavonoids and fatty acid esters from leaves and rhizomes for phytochemical analysis; not available in commercial supplement form.
**Decoction (Ethnomedicinal)**
Rhizomes may be boiled in water for bronchodilator or anti-inflammatory use in some Pacific and Southeast Asian traditional systems; no volume, concentration, or frequency has been standardized.
**Commercial Supplement Forms**
No capsule, tablet, tincture, or standardized extract of Phymatosorus scolopendria is commercially available; all dosing information is extrapolated from in vitro research and ethnomedicinal reports only.
**Timing and Duration**
No evidence-based guidance on timing or duration of use exists; traditional applications appear to be episodic and symptom-driven rather than scheduled.
Nutritional Profile
Phymatosorus scolopendria has not been characterized as a food or nutritional supplement, and no macronutrient or micronutrient composition data are available from dietary analysis. Phytochemical profiling reveals phenolic acids constituting 46–57% relative abundance in extracts, including protocatechuic acid 4-O-glucoside (1.78–2.19%), p-coumaroyl tartaric acid (~28% in leaf hexane extract), and feruloyl tartaric acid (~12.8%). Flavonoids including isoxanthohumol (~9.09%), cirsimaritin (~8.45%), daidzein (~10.85%), and pyrogallol (~9.32%) are present in rhizome and leaf extracts, alongside stilbenes such as resveratrol at 0.13–1.23%. Fatty acid derivatives identified by GC-MS include myristic acid vinyl ester (~53.29% peak area) and hexadecanoic acid 4-nitrophenyl ester (~10.82%); bioavailability of these compounds from any ingested or topically applied preparation has not been studied.
How It Works
Mechanism of Action
Flavonoids cirsimaritin and kaempferide competitively inhibit cyclooxygenase-2 (COX-2) while largely sparing COX-1, reducing arachidonic acid conversion to pro-inflammatory prostaglandins and providing a mechanistic basis for the anti-inflammatory and wound-healing effects. Isoxanthohumol, resveratrol, and kaempferide suppress bacterial biofilm by downregulating the rsbU sigma factor regulatory gene and the protein A gene (spa) in Staphylococcus epidermidis, impairing surface adhesion, intercellular communication via quorum sensing, and α-toxin secretion. Phenolic acids including p-coumaroyl tartaric acid and feruloyl tartaric acid contribute to antioxidant activity through hydrogen atom transfer and electron donation mechanisms, chelating transition metals and scavenging reactive oxygen species. Fatty acid esters identified by GC-MS, particularly myristic acid vinyl ester (53.29% peak area) and 4-nitrophenyl laurate (26.91%), are implicated in antiviral and additional antibacterial effects, though their specific molecular targets in human tissues remain uncharacterized.
Clinical Evidence
No human clinical trials have been conducted on Taulalo (Phymatosorus scolopendria) for any indication, including its primary traditional uses of wound and sore treatment. All available quantitative data derive from in vitro studies, including anti-biofilm assays showing activity at 128 µg/mL against S. epidermidis and DPPH antioxidant assays demonstrating moderate free-radical scavenging below the potency of gallic acid and ascorbic acid. Effect sizes from these in vitro models cannot be directly extrapolated to clinical outcomes due to the absence of bioavailability, pharmacokinetic, or toxicological data in mammalian systems. Confidence in claimed benefits remains low, and therapeutic use in any human population should be considered unsupported by clinical evidence until appropriately designed trials are completed.
Safety & Interactions
No systematic toxicological studies, human safety trials, or documented adverse event reports exist for Phymatosorus scolopendria in any preparation form, and no maximum safe dose, LD50, or NOAEL has been established. Ethnomedicinal use across Pacific and Southeast Asian communities over extended periods suggests a low acute toxicity profile for topical applications, but this does not constitute evidence of safety for internal consumption or concentrated extract use. Drug interactions have not been investigated; however, the presence of daidzein (a phytoestrogen) and resveratrol (a known CYP1A2 and CYP3A4 modulator in high doses) raises theoretical concerns about interactions with hormonal therapies, anticoagulants, and hepatically metabolized pharmaceuticals. Use during pregnancy and lactation cannot be assessed due to the complete absence of reproductive toxicology data, and avoidance is prudent until evidence is available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Phymatosorus scolopendriaMicrosorum scolopendriaTaulaloMusk fernScaly polypodyBreadfruit fern
Frequently Asked Questions
What is Taulalo used for in Samoan traditional medicine?
In Samoan ethnomedicine, Taulalo (Phymatosorus scolopendria) is primarily used as a topical remedy for skin sores and wounds, and is considered functionally similar to the related fern awawa (Microsorum grossum). The plant is typically prepared as a crushed poultice from fresh leaves and applied directly to affected skin, drawing on its antimicrobial and anti-inflammatory phytochemical content documented in in vitro research.
What active compounds are found in Phymatosorus scolopendria?
Phymatosorus scolopendria contains a diverse array of bioactive compounds including phenolic acids such as p-coumaroyl tartaric acid (~28% of hexane leaf extract) and protocatechuic acid 4-O-glucoside, flavonoids including cirsimaritin, isoxanthohumol, daidzein, and kaempferide, and the stilbene resveratrol at concentrations of 0.13–1.23%. GC-MS analysis of methanolic leaf extracts also identifies fatty acid derivatives including myristic acid vinyl ester and hexadecanoic acid 4-nitrophenyl ester with reported antiviral and antibacterial properties.
Is there scientific evidence that Taulalo works for inflammation or infections?
Current evidence is limited to in vitro laboratory studies with no human clinical trials published. In vitro data show anti-biofilm activity against Staphylococcus epidermidis at 128 µg/mL, selective COX-2 inhibition by cirsimaritin and kaempferide, and moderate DPPH radical scavenging activity, though antioxidant potency is lower than reference compounds gallic acid and vitamin C. These findings are promising but cannot be directly translated into confirmed human health benefits without clinical investigation.
Are there any known side effects or safety concerns with Taulalo?
No systematic toxicology studies or human safety trials have been conducted on Phymatosorus scolopendria, so side effects, drug interactions, and contraindications cannot be formally characterized. The presence of the phytoestrogen daidzein and the CYP enzyme-modulating compound resveratrol raises theoretical concern about interactions with hormonal medications and drugs metabolized by CYP1A2 or CYP3A4. Use during pregnancy or lactation is not recommended due to the complete absence of reproductive safety data.
What is the recommended dose of Taulalo supplement?
No established therapeutic dose, standardized supplement form, or commercially available preparation of Phymatosorus scolopendria exists. In vitro research used crude extracts at concentrations such as 128 µg/mL for anti-biofilm studies, but these laboratory concentrations have no validated equivalent human dose. Traditional use is topical and empirical, and any internal or supplemental use would currently lack evidence-based dosing guidance.
Does Taulalo interact with antibiotic medications or antimicrobial treatments?
While Taulalo demonstrates in vitro antimicrobial activity against S. epidermidis, there is limited clinical data on interactions with prescription antibiotics. Because Taulalo may have biofilm-disrupting properties, concurrent use with antibiotics should be discussed with a healthcare provider to ensure complementary rather than conflicting mechanisms. No major interactions with common antibiotic classes have been documented, but individual response may vary based on the specific infection and medication combination.
Is Taulalo more effective as a topical preparation or oral supplement for wound healing?
Taulalo is traditionally applied topically to sores and wounds in Samoan medicine, which aligns with in vitro evidence showing direct antimicrobial and anti-biofilm activity at the tissue level. Oral supplementation may support systemic anti-inflammatory effects through COX-2 inhibitory flavonoids, but scientific evidence specifically comparing topical versus oral delivery is limited. Topical application appears more directly targeted for localized wounds, while oral use may complement broader inflammatory support.
What is the evidence quality for Taulalo's wound-healing claims compared to conventional antimicrobial treatments?
Current evidence for Taulalo is limited to in vitro studies demonstrating biofilm disruption and antimicrobial activity; human clinical trials are lacking. The isoxanthohumol and resveratrol compounds show promise at specific concentrations (128 µg/mL), but these lab conditions may not directly translate to real-world efficacy or optimal dosing in topical formulations. While traditional use is established, Taulalo should be considered a complementary option rather than a proven replacement for evidence-based wound care protocols.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w taulalo-phymatosorus-scolopendria curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
